Buprenorphine plus naltrexone shot to prevent opioid relapse
Treatments studied
Part of Mental health clinical trials.
This trial tests whether a combination of buprenorphine (through your care plan) and a monthly extended-release naltrexone (XR-NTX) shot can help prevent opioid relapse. It may help people who are ready to move toward a naltrexone-based relapse-prevention treatment after detox.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 65 and want relapse-prevention treatment for opioid use disorder
- Have opioid use disorder for at least 6 months, with recent opioid evidence on urine testing (or you recently completed detox/induction)
- Have completed opioid detox and received XR-NTX, or can start XR-NTX induction within 2 weeks of a previous XR-NTX injection
- Be medically healthy enough for study procedures (physical exam, blood/urine tests, ECG) with no major abnormal results
- Be able and willing to sign consent and understand the difference between “agonist” and “antagonist” treatment
- Agree you are a good candidate for naltrexone-based treatment (your clinician’s judgment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers buprenorphine (a medication for opioid use disorder) to people in jail who are soon to be released. It helps you start treatment while incarcerated and continue it after you return to the community, aiming to reduce overdose and improve recovery.
This study tests a long-acting implant that releases naltrexone slowly over time to help prevent relapse in people with opioid use disorder. The implant is placed under the skin in a minor procedure and may help you stay opioid-free.
This study tests a faster way to start buprenorphine (a medication for opioid use disorder) by using naloxone to briefly trigger mild withdrawal. This could help people get started on treatment more comfortably and quickly.
This study compares two forms of a medication called buprenorphine (one is a pill you take under the tongue, the other is an injection) to see which works better for treating opioid use disorder. If you are eligible, you will receive one of these forms for a year and regular check-ups.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
This study tests whether a once-monthly injection of buprenorphine (called extended-release buprenorphine, or XR-B) works well for people in prison who are already in a medication program for opioid use disorder. It looks at preferences and outcomes in the last months before release.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.